Vivos therapeutics to participate in fireside chat at the 35th annual roth conference

Littleton, colo., march 08, 2023 (globe newswire) -- vivos therapeutics, inc. (the “company” or “vivos”) (nasdaq:vvos), a medical device and technology company that delivers training and a full line of highly effective proprietary oral appliances for the treatment of breathing related sleep disorders in adults, including mild-to-moderate obstructive sleep apnea (osa) and snoring, today announced that kirk huntsman, vivos' chairman and ceo and brad amman, cfo, will participate in a fireside chat at the 35th annual roth conference on tuesday, march 14, 2023 at 1:30 pm pt (4:30 pm et).
VVOS Ratings Summary
VVOS Quant Ranking